Effects of ranibizumab (Lucentis (R)) and bevacizumab (Avastin (R)) on human corneal endothelial cells

Merz, PR; Rockel, N; Ballikaya, S; Auffarth, GU; Schmack, I

Auffarth, GU (reprint author), Heidelberg Univ, Dept Ophthalmol, Lions Eye Bank, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.

BMC OPHTHALMOLOGY, 2018; 18 ():

Abstract

BackgroundIngrowth of newly formed blood and lymph vessels (angiogenesis) from the limbus region into the cornea can be treated successfully by subcon......

Full Text Link